Abstract
The landscape of penile prosthesis (PP) implantation has recently experienced a significant paradigm shift. With the advent of antibiotic-impregnated devices, hydrophilic coatings, and the “no-touch” surgical technique,1 postimplantation infection risk has significantly decreased. Whether these altered risk profiles apply to a patient with diabetes mellitus (DM) is still up for question.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
